 | Up a level |
Fournier, A; Eggimann, P; Pantet, O; Pagani, J L; Dupuis-Lozeron, E; Pannatier, A; Sadeghipour, F; Voirol, P; Que, Y.-A. (2018). Reply to Sorooshian and Snow, "Is Alternate-Day Therapeutic Drug Monitoring in the Intensive Care Unit Not Intensive Enough?". Antimicrobial agents and chemotherapy, 62(10) American Society for Microbiology 10.1128/AAC.01343-18
Fournier, A; Eggimann, P; Pantet, O; Pagani, J L; Dupuis-Lozeron, E; Pannatier, A; Sadeghipour, F; Voirol, P; Que, Yok-Ai (2018). Impact of Real-Time Therapeutic Drug Monitoring on the Prescription of Antibiotics in Burn Patients Requiring Admission to the Intensive Care Unit. Antimicrobial agents and chemotherapy, 62(3) American Society for Microbiology 10.1128/AAC.01818-17
Plüss-Suard, C; Pannatier, A; Kronenberg, Andreas; Mühlemann, K; Zanetti, G (2013). Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: is there a role for antibiotic diversity? Antimicrobial agents and chemotherapy, 57(4), pp. 1709-13. Washington, D.C.: American Society for Microbiology 10.1128/AAC.01348-12
Plüss-Suard, C; Pannatier, A; Ruffieux, C; Kronenberg, Andreas; Mühlemann, K; Zanetti, G (2012). Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysis. Antimicrobial agents and chemotherapy, 56(2), pp. 989-94. Washington, D.C.: American Society for Microbiology 10.1128/AAC.05560-11
Devaud, J-C; Berger, M M; Pannatier, A; Marques-Vidal, P; Tappy, L; Rodondi, N; Chiolero, R; Voirol, P (2012). Hypertriglyceridemia: a potential side effect of propofol sedation in critical illness. Intensive care medicine, 38(12), pp. 1990-8. Berlin: Springer 10.1007/s00134-012-2688-8
Plüss-Suard, C; Pannatier, A; Kronenberg, Andreas; Mühlemann, K; Zanetti, G (2011). Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe. Journal of hospital infection, 79(2), pp. 166-71. Kidlington, UK: Elsevier 10.1016/j.jhin.2011.05.028
